Navigation Links
Clinical trial that may help patients breathe easier begins at Central DuPage Hospital
Date:4/1/2008

WINFIELD, Ill., April 1, 2008 Researchers at Suburban Lung Associates and the Chicago Chest Center recently announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial to explore an investigational treatment for advanced widespread emphysema. The trial focuses on airway bypass, a minimally invasive bronchoscopic procedure designed to help patients with emphysema/COPD (chronic obstructive pulmonary disease) breathe more easily.

Central DuPage Hospital is the only site for the EASE trial in the Chicago area. Airway bypass could be groundbreaking because it is a potential non-surgical treatment for the patient with diffuse emphysema, states Dr. Kevin Kovitz, interventional pulmonologist and principal investigator of the study at the Central DuPage Hospital site. Emphysema, which permanently destroys lung function, is such a devastating disease, and any potential new treatment option could offer substantial relief to the millions who struggle with each breath.

During the airway bypass procedure, new openings are created in the airway wall connecting the damaged lung tissue to the natural airway. These pathways are supported and kept open by Exhale® Drug-Eluting Stents manufactured by Broncus Technologies, Inc. Patients could see an immediate improvement in shortness of breath.

Emphysema, a type of COPD, is a chronic, progressive and irreversible lung disease characterized by the destruction of lung tissue. The loss of the lungs' natural elasticity and the collapse of airways in the lung combine to leave emphysema sufferers unable to get air out of their lungs. As a result, patients have to work very hard just to breathe, making normal activities, like walking, eating or even bathing, difficult. There are few treatment options for most patients with emphysema and there is no cure.

If proven, the airway bypass procedure could be an excellent option for those who are not suitable candidates
'/>"/>

Contact: Meghan Oreste
moreste@comcast.net
617-823-1441
Broncus Technologies
Source:Eurekalert  

Page: 1 2

Related biology news :

1. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
2. Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients
3. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
4. Cleveland Clinic leading clinical program to improve early-stage lung cancer detection
5. Singulex Teams With Wyeth Pharmaceuticals to Translate Pre-Clinical Biomarker Research Into Clinical Study Design
6. Study of African traditional medicine will begin world-first clinical trial
7. New clinical data shows chromium picolinate improves cognitive function
8. New clinical trial results show how personalized medicine will alter treatment of genetic disorders
9. Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic
10. Simple screening questionnaire for kidney disease outperforms current clinical practice guidelines
11. NHLBI issues first US von Willebrand Disease clinical practice guidelines

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Clinical trial that may help patients breathe easier begins at Central DuPage Hospital
Clinical trial that may help patients breathe easier begins at Central DuPage Hospital
(Date:11/26/2009)... Aureus ) and other drug-resistant bacteria could ...ype devices have been developed to offer safe, qui... Two prototype devices have been developed: one fo...ds and feet) in hospitals and public spaces where ...shoot bacteria-killing agents into infested chroni...
(Date:11/25/2009)...ers and ambulance workers faced a terrifying rescu...attled to save people from the collapsing Twin Tow...cuated as many people as they could in an area whi...g their jobs even harder was the problem of poor c...ves jammed mobile networks with calls and the emer...
(Date:11/25/2009)...ors recently received funding from the National Sc...cial to understanding the environment. The three g...ssistant professor in the Department of Biological...ate research projects. , His first project, titl...unctions from the Leaf to the Landscape," will exa...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate Says Aon Consultings Radford 48659 1Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate Says Aon Consultings Radford 48659 2Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate Says Aon Consultings Radford 48659 3Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate Says Aon Consultings Radford 48659 4Actuaries Weigh in on Ways to Address Risk Exposures and Challenges with the U S Health Care System 48656 1Actuaries Weigh in on Ways to Address Risk Exposures and Challenges with the U S Health Care System 48656 2Actuaries Weigh in on Ways to Address Risk Exposures and Challenges with the U S Health Care System 48656 3Actuaries Weigh in on Ways to Address Risk Exposures and Challenges with the U S Health Care System 48656 4Cornflakes White Bread Could Boost Heart Risk 48653 1Cornflakes White Bread Could Boost Heart Risk 48653 2Cornflakes White Bread Could Boost Heart Risk 48653 3
...ook For Biometrics Revenue and Profit Growth, WAL...Bulletin Board: BKYI), a leader in wireless public...solutions, today announced its,financial results f...tal revenue from continuing operations for the thr...n representing a 27% decrease from the,$3.0 millio...
...a. --- The observation that males evolve more quic...y biologist Charles Darwin noted the majesty of a ...ness of the peahens. , No matter the species, mal...elodious warbles in an eternal competition to win ...n. , Why males are in evolutionary overdrive even...
...s prepare to discuss conservation-friendly carbon ...s a new wave of deforestation in the South America...t Anglia and Brazils Goeldi Museum highlights once...n forest. , Working in the north-eastern Brazili...ertook the single-largest assessment of the biodiv...
Other Biology News:BIO-key Reports Third Quarter 2007 Results 2BIO-key Reports Third Quarter 2007 Results 3BIO-key Reports Third Quarter 2007 Results 4BIO-key Reports Third Quarter 2007 Results 5Simple reason helps males evolve more quickly 2Simple reason helps males evolve more quickly 3Single-largest biodiversity survey says primary rainforest is irreplaceable 2
(Date:11/24/2009)...,, REYKJAVIK,Iceland,November24/PRNewswire-F...yannouncedtheapprovalofallofits,"firstday"motionsb...he"BankruptcyCourt").deCODElastweekfiledavoluntary...ankruptcyCodewiththe,BankruptcyCourt. , Theor...tinue,tooperateitsbusinessduringtheChapter11procee...
(Date:11/24/2009)...,, SEATTLE,Nov.24/PRNewswire/--BlueMarbleEne...blicDevelopmentAuthority(OPDA)wererecentlyawarded$...lizationBoard(CERB)inaprivate/publicpartnershiptoc...neryinLincolnCounty,WA. ,, "Thisinvestmentwills...bringover70greenjobstoLincolnCounty,"saidBlueMarbl...
(Date:11/24/2009)...,, DUBLIN,November24/PRNewswire-FirstCall/--...tybiopharmaceuticalcompany,today,announcedthatitha...glucerasealfa,thecompany,senzymereplacementtherapy....Thisisthethirdmarketing,applicationforvelaglucera...sintheUnitedStatesandCanada. , Basedonaglobal...
(Date:11/24/2009)..., Program Connects Custom... Samples Collected with DNA Genotek Products , ...24, 2009 -- DNA Genotek , a leading provider of p...ation and preparation, today announced its new glo...t enhancements for DNA Genotek,s partner community...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...ons has,long been used as a marketing tool by the ...bility to reach consumers has never been greater. ...joined the traditional press,release as effective ...his,understanding, new research was conducted by B...ns activities are most effective at educating,and ...
...ytics Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) announ...nterim results of a U.S. Phase II trial investigat...and soft tissue sarcomas metastatic to,the lung is...nstitute of,Drug Development (IDD), the Cancer The...s Health Science Center, (UTHSC), San Antonio, Tex...
...d its annual "Power of Partnership" award to Baxte...cal device and specialty pharmaceutical,company. B...ibution,Management Association,s (HDMA) Annual Lea...Power of Partnership" award was created by AmeriCa...d distribution organizations that have,shown excep...
Other Biology Technology:New Study Shares Best Practices in Biopharma Public Relations 2Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data 2Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data 3AmeriCares Presents 'Power of Partnership' Award to Baxter 2AmeriCares Presents 'Power of Partnership' Award to Baxter 3
Expansion and Cryopreservation of Cells from Meridian Life Science, Inc.
HandyStep manual repeating pipette from BrandTech Scientific
Zymo-Spin I-96 from Zymo Research
RT-PCR Grade Water from Ambion
Biology Products: